|Articles|January 9, 2017

Guide to understanding MACRA

Trying to make sense of the Medicare Access and Chip Reauthorization Act of 2015? We're here to help.

More resources on MACRA

An easy guide to MACRA's reporting options

Is DPC a viable way to MACRA-proof your practice?

MACRA: Small practice hug or regulatory choke hold?

Newsletter

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Subscribe

Related Content

What direct-to-employer GLP-1 purchasing means for primary care physicians

ByAustin Littrell

June 29th 2026

Is your AI chatbot leaking patient data?

ByTodd Shryock

June 29th 2026

Dave S. Gilreath: ©Allworth Financial LP

As materials and industrials climb together, so does investor opportunity

ByDave S. Gilreath, CFP

June 29th 2026

Off the Chart: A Business of Medicine Podcast - Ep. 163: What physicians need to know about Medicare's new obesity drug coverage, with Tracy Zvenyach, Ph.D., M.S., RN, of the Obesity Action Coalition

What physicians need to know about Medicare's new obesity drug coverage, with Tracy Zvenyach, Ph.D., M.S., RN, of the Obesity Action Coalition

ByAustin Littrell

June 29th 2026

FDA approves device for ex vivo lung perfusion: ©Mi Viri - stock.adobe.com

FDA approves first device for centralized ex vivo lung perfusion of donor lungs

ByTodd Shryock

June 29th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Guide to understanding MACRA

More resources on MACRA

Related Content

What direct-to-employer GLP-1 purchasing means for primary care physicians

Is your AI chatbot leaking patient data?

As materials and industrials climb together, so does investor opportunity

What physicians need to know about Medicare's new obesity drug coverage, with Tracy Zvenyach, Ph.D., M.S., RN, of the Obesity Action Coalition

FDA approves first device for centralized ex vivo lung perfusion of donor lungs

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

FDA approves first device for centralized ex vivo lung perfusion of donor lungs

As materials and industrials climb together, so does investor opportunity

Why interoperability is shifting from a tech problem to a money problem

Independent practices and Medicare: Why a ‘low-paying’ panel may be your most important asset

Is your AI chatbot leaking patient data?